CYP2E1 expression in human lymphocytes from various ethnic populations

Alcoholism: Clinical and Experimental Research

Volumn 23, Issue 12, 1999, Pages 1868-1874

  Raucy, Judy L ^b   Schultz, Eric D ^c   Kearins, Margaret C ^c   Arora, Sanjeev ^c   Johnston, David E ^c   Omdahl, John L ^c   Eckmann, Lars ^a   Carpenter, Susan P ^c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b La Jolla Institute for Experimental Medicine   (United States)

^c NONE

Author keywords

Chlorzoxazone; CYP2E1; Ethnicity; Genotype; Lymphocyte

Indexed keywords

CHLORZOXAZONE; CYTOCHROME P450 ISOENZYME; LIVER ENZYME; M PROTEIN; MESSENGER RNA;

ADULT; ALCOHOL LIVER DISEASE; ALCOHOLISM; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG CLEARANCE; ENZYME ACTIVITY; ETHNIC GROUP; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 0033376610     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1999.tb04085.x     Document Type: Article

References (25)

1. Bachmann K, Sarver JG (1996) Chlorzoxazone as a single sample probe of hepatic CYP2E1 activity in humans. Pharmacology 52:169-177.
2. Carpenter SP, Lasker JM, Raucy JL (1996) Expression, induction, and catalytic activity of the ethanol-inducible cytochrome P450 (CYP2E1) in human fetal liver and hepatocytes. Mol Pharmacol 49:260-268.
3. Dreisbach AW, Ferencz N, Hopkins NE, Fuentes MG, Rege AB, George WJ, Lertora JJ (1995) Urinary excretion of 6-hydroxychlorzoxazone as an index of CYP2E1 activity. Clin Pharmacol Ther 58:498-505.
4. Ewing JA (1984) Detecting alcoholism: The CAGE questionnaire. JAMA 252:1905-1907.
5. Grant BF, Hasin DS (1990) Alcohol Use Disorders and Associated Disabilities Interview Schedule (AUDADIS). National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD.
6. Hayashi S, Watanabe J, Kawajiri K (1991) Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 110:559-565.
7. Ingelman-Sundberg M, Johansson I, Hu Y, Terelius Y, Eliasson E, Clot P, Albano E (1993) Ethanol-inducible cytochrome P4502E1:Genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease. Alcohol 10:447-452.
8. Jung HC, Eckmann L, Yang S-K, Panja A, Fierer J, Morzycka-Wroblewska E, Kagnof MF (1995) A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 95:55-65.
9. Kato SS, Shields PG, Caporaso NE, Hoover RN, Trump BF, Sugimura H, Weston A, Harris CC (1992) Cytochrome P450IIE1 genetic polymorphism, racial variation and lung cancer risk. Cancer Res 52:6712-6715.
10. Lucas D, Berthou F, Girre C, Poitrenaud F, Menez J-F (1993) High-performance liquid chromatographic determination of chlorzoxazone and 6-hydroxychlorzoxazone in serum: A tool for indirect evaluation of cytochrome P4502E1 activity in humans. J Chromatogr 622:79-86.
11. Lucas D, Menez C, Girre C, Berthou F, Bodenez P, Joannet I, Hispard E, Bardou L-G, Menez J-F (1995) Cytochrome P450 2E1 genotype and chlorzoxazone metabolism in healthy and alcoholic Caucasian subjects. Pharmacogenetics 5:298-304.
12. Mayfield DG, McLeod G, Hall P (1974) The CAGE questionnaire: Validation of a new alcoholism screening instrument. Am J Psychiatry 131:1121-1123.
13. McCarver DG, Byun R, Hines RN, Hichme M, Wegenek W (1998) A genetic polymorphism in the regulatory sequences of human CYP2E1: Association with increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake. Toxicol Appl Pharmacol 152:276-281.
14. Nedelcheva V, Persson I, Ingelman-Sundberg M (1996) Genetic polymorphism of human cytochrome P450 2E1. Methods Enzymol 272:218-225.
15. National Institute on Alcohol Abuse and Alcoholism (1993) Eighth Special Report to the U.S. Congress on Alcohol and Health. 8th ed, pp 277-278. Department of Health and Human Services, Alexandria, VA.
16. Powell H, Kitteringham NR, Pirmohamed M, Smith DA, Park BK (1998) Expression of cytochrome P4502E1 in human liver: Assessment by mRNA, genotype and phenotype. Pharmacogenetics 8:411-421.
17. Raucy JL, Lasker JM (1991) Isolation of P450 enzymes from human liver. Methods Enzymol 206:577-587.
18. Raucy JL, Curley G, Carpenter SP (1995) The use of lymphocytes for assessing ethanol-mediated alterations in the expression of hepatic CYP2E1. Alcohol Clin Exp Res 19:1369-1375.
19. Raucy JL, Schultz ED, Wester MR, Arora S, Johnston DE, Omdahl JL, Carpenter SP (1997) Human lymphocyte cytochrome P450 2E1, a putative marker for alcohol-mediated changes in hepatic chlorzoxazone activity. Drug Metab Dispos 25:1429-1435.
20. Roberts BJ, Song BJ, Soh Y, Park SS, Shoaf SE (1995) Ethanol induces CYP2E1 by protein stabilization. Role of ubiquitin conjugation in the rapid degradation of CYP2E1. J Biol Chem 270:29632-29635.
21. Soh Y, Rhee HM, Sohn DH, Song BJ (1996) Immunological detection of CYP2E1 in fresh rat lymphocytes and its pretranslational induction by fasting. Biochem Biophys Res Commun 227:541-546.
22. Tsutsumi M, Lasker JM, Shimizu M, Rosman AS, Lieber CS (1989) The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver. Hepatology 10:437-446.
23. Uematsu F, Kikuchi H, Motomiya M, Abe T, Sagami I, Ohmachi T, Wakui A, Kanamaru R, Watanabe M (1991) Association between restriction fragment length polymorphism of the human cytochrome P450IIE1 gene and susceptibility to lung cancer. Jpn J Cancer Res 82:254-256.
24. Wu XF, Shi HH, Jiang H, Kemp B, Hong WK, Delclos GL, Spitz MR (1997) Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis 18:967-973.
25. Wu XF, Amos CI, Kemp BL, Shi HH, Jiang H, Wan Y, Spitz MR (1998) Cytochrome P450 2E1 DraI polymorphisms in lung cancer in minority populations. Cancer Epidemiol Biomarkers Prev 7:13-18.